As leader of ZS’s strategy and transformation practice area in the Asia-Pacific region, Kelly helps clients at leading pharma and medtech companies address an array of business and organizational challenges. Kelly’s leadership is characterized by close collaboration with her clients in the development and implementation of innovative solutions and driving transformative impact and strategies.

Since 2010, Kelly has been a go-to-market expert and trusted adviser in commercialization and transformation across a broad range of therapeutic areas and consumer health categories. She navigates the complexities of healthcare regulations in China and the Asia-Pacific region, supporting clients in transformative initiatives that drive patient-centric capabilities and personalized experiences for improved outcomes. Kelly’s strategic approach—blending vision, experience and leadership—empowers her to consistently deliver results for clients in the dynamic healthcare landscape.

Prior to ZS, Kelly worked with a global top leadership advisory firm and led innovative technology launches at Abbott Laboratories as commercialization director of greater China. Kelly started her career at the DuPont Global Marketing Leadership Development Program.

Kelly holds an MBA from Duke University and a B.A. in international trade from East China University.